Despite a steady increase in the number of HIV-positive people receiving antiretroviral treatment in Indonesia, only about 15,000 of the estimated 200,000 HIV-positive people in the country are receiving the drugs, Samsuridjal Djauzi, chair of the Association of Indonesian Physicians Concerned About HIV/AIDS, said at a conference Friday, the Jakarta Post reports.Advertisement
Speaking at the 2008 Clinical Research Meeting on HIV/AIDS in Jakarta, Djauzi said the Indonesian government has not provided enough funds to keep up with the demand for antiretrovirals, particularly imported drugs. In addition, a lack of general knowledge of the disease among some HIV-positive people also has negatively affected treatment access, he said.
According to Djauzi, most patients currently taking antiretrovirals are taking a first-line therapy -- only 5% of HIV-positive Indonesians are treated with second-line drugs. He said the country could face a supply shortage of the first-line antiretroviral Efavirenz, the only first-line therapy Indonesia imports. If such a shortage occurs, resistance to first-line antiretrovirals would increase, and the country would be forced to put more patients on more expensive second-line therapies, Djauzi said.
According to the Post
, the conference is being attended by experts and physicians from community health centers, hospitals and prisons throughout the country (Maulia, Jakarta Post
Back to other news for April 2008
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.